DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

152.26 -4.11 (-2.63%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $152.26 -2.63%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $155.55
Previous Close $156.37
Daily Range $151.53 - $156.87
52-Week Range $108.20 - $173.14
Market Cap $115.8B
P/E Ratio 17.97
Dividend (Yield) $3.16 (2.0%)
Ex-Dividend Date
Dividend Pay Date
02/10/15
03/06/15
Volume 5,326,614
Average Daily Volume 3,619,280
Current FY EPS $9.29

Sector

Healthcare

Industry

Drugs

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary

Can Biotech Duplicate Its 2014 Performance, or Is It Time to Jump Ship?

Three Motley Fool healthcare contributors share thoughts on whether biotech stocks can go higher this year.

Big Pharma: An Up-Close Look at One Key Player

Industry Focus zooms in on restructuring, new drugs, and possible threats for pharma giant Novartis.

Can You Guess What Legal Drug Outsells the NFL?

The NFL is unquestionably one of the most successful American businesses of all-time. Surprisingly, though, the NFL's 2013 revenues were no match for this single legal drug.

Amgen Offers Impressive Upside As A New Product Cycle Begins

3 Biotech Giants That Shouldn't Pay a Dividend

Three Motley Fool contributors explain why they don't want these large-cap biotech companies to pay a dividend.

Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More

Protalex Aiming At Rheumatoid Arthritis Market With A Much Cheaper Price Tag

$CTIX - Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon

My Dividend Portfolio: 2014 Year In Review

Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog

Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog

See More AMGN News...

AMGN's Top Competitors

AMGN $152.26 (-2.63%)
Current stock: AMGN
GILD $104.83 (0.62%)
Current stock: GILD
CELG $119.16 (-1.41%)
Current stock: CELG
$0.00 (0.00%)
Current stock: